Introducing TruSight Oncology Comprehensive (EU), the first CE-marked IVD test kit for comprehensive genomic profiling based on DNA and RNA that consolidates multiple iterative tests into one. Provide precision oncology in your institution and help inform therapy decisions according to clinical guidelines.
Learn MoreLearn how you can maximize identification of molecularly matched therapies. One biopsy, one test, one report can lead to improved patient outcomes.
Download eBookDr. Stephanie Hastings discusses critical workflow and bioinformatics considerations when consolidating individual biomarkers into a single NGS-based liquid biopsy assay for clinical research.
Watch Webinar